Concepedia

Publication | Open Access

Efficacy and Safety of Keverprazan Compared With Lansoprazole in the Treatment of Duodenal Ulcer: A Phase III, Randomized, Double-Blind, Multicenter Trial

DOIFull Paper Access

14

Citations

17

References

2023

Year

Niandi Tan, Xin-Pu Miao, Aijun Liao, Chengxia Liu, Hao Wu, Honghui Chen, Fangfang Li, Qinghong Guo, Shengbao Li, Yanping Tang,
Clinical and Translational Gastroenterology

Abstract

Keverprazan 20 mg had a good safety profile and was noninferior to lansoprazole 30 mg once daily for DU healing.

References

YearCitations

Page 1